Service providers

AdaptVac

Solution provided
Supplier indentity
General description
AdaptVac’s core business is the development of vaccines for infectious diseases and cancer. AdaptVac combines a highly competitive recombinant antigen production platform with a unique virus-like particle (VLP) vaccine platform. This proprietary technology is the first achieving true VLP display of large and complex antigens. The overall strength of this technology platform is the ability to develop, with a minimal effort and alteration, any recombinant vaccine candidate into a VLP particle.
Type of supplier
Biotechnology Company - Therapeutics, Lab/scientific services platform
Sector of activity:
Activity description
Services provided
AdaptVac's VLP display technology can be used in collaboration with SMEs to improve their sub-unit vaccines against infectious diseases and cancer. We can support formulation development and production and VLP display of their vaccine antigens. Furthermore, AdaptVac has access to animal facilities to test potential vaccines and adjuvants in combination with our VLP technology.
Terms of availability for SMEs
No
Quality labels and accreditations
No
Region
Denmark, DK
Contact information
Name
Wian de Jongh
Function
CEO
Phone number
004526394649
Email address
Address
Agern alle 1
2970 horsholm
Denmark
Partner contact information
Company name
Biopeople
Phone number
Address
Universitetsparken 2
2100 Copenhagen

Upcoming events

10
Oct
10 Oct 2019GeleenNederland

Biomedica On The Move is a novel format dedicated to business creation for SME’s in the Euregion. We bring the networks together and let interaction, matching and valorisation take place. The event is focused and highly interactive.

Every single edition of Biomedica On The Move is meant as an exclusive event for people who are determined to explore business opportunities in the Euregion!

Agenda

Mo Tu We Th Fr Sa Su
 
 
 
1
 
2
 
3
 
4
 
5
 
6
 
7
 
8
 
9
 
10
 
11
 
12
 
13
 
14
 
15
 
16
 
17
 
18
 
19
 
20
 
21
 
22
 
23
 
24
 
25
 
26
 
27
 
28
 
29
 
30
 
31